Literature DB >> 9784000

Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans.

P Greaves1.   

Abstract

In toxicity studies, the examination of tissue sections for pathological changes is the principle method for the identification of organ toxicity and characterisation of the hazard of novel drugs for humans. Study of the patterns of pathological alterations also represents an important means of developing an understanding of the mechanism of toxicity. However as pathological change frequently represents a final common expression of diverse processes, additional functional information is often required for a clear understanding of the mechanisms of toxicity. This is exemplified in the evaluation of the effects of drugs on the beagle dog cardiovascular system where an understanding of mechanisms is crucial in the assessment of human risk. Particular patterns of drug-induced structural change in the myocardium or blood vessels are frequently linked to specific mechanisms of toxicity. However, assessment based on the interpretation of patterns of cardiovascular pathology alone may be misleading. Quite different changes in cardiac and vascular function or direct cellular toxicity may also be manifest by pathological features in common. Therefore, a clear understanding of mechanism frequently requires additional in vivo or in vitro physiological, pharmacological, biochemical or other mechanistic information. The beagle dog remains an important model for the study of cardiovascular toxicity because in this species, haemodynamic changes and pathological alterations can be related in a way that provides the basis for the safe study in humans of novel drugs with cardiovascular activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784000     DOI: 10.1016/S0940-2993(98)80008-0

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  3 in total

1.  Effect of Wearing a Telemetry Jacket on Behavioral and Physiologic Parameters of Dogs in the Open-Field Test.

Authors:  Richard E Fish; Melanie L Foster; Margaret E Gruen; Barbara L Sherman; Davidc C Dorman
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-07-01       Impact factor: 1.232

2.  Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.

Authors:  David A Brott; Anne Katein; Heath Thomas; Michael Lawton; Robert R Montgomery; Rudy J Richardson; Calvert S Louden
Journal:  Toxicol Pathol       Date:  2014-02-04       Impact factor: 1.902

3.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.